Sterile Injectable Capacity, Expansion & Commercial Scale-Up Summit 2027

16–17 March 2027 | Düsseldorf, Germany

The only executive-level B2B marketplace addressing the global sterile fill-finish capacity crunch, capital scale-up economics, and high-speed commercial execution.

2027 Registration

The Capacity Crisis Demands a Business Solution

The global sterile injectable sector is caught in an unprecedented multi-billion-dollar capacity squeeze. The skyrocketing demand for blockbuster GLP-1 metabolic therapies, complex biologics, and next-gen biosimilars has completely saturated the world’s commercial aseptic lines.
While legacy technical conferences spend days reading regulatory texts or debating lab validation, the Sterile Injectable Capacity, Expansion & Commercial Scale-Up Summit 2027 is built to do one thing: enable high-speed commercial execution.
Taking place right in the heart of Europe’s premier pharmaceutical manufacturing corridor—Düsseldorf—this summit is a dedicated, fast-paced commercial marketplace. We bring together the decision-makers holding the budgets to solve real-world industrial bottlenecks: scaling to hundreds of millions of units, financing massive capital projects, managing “Take-or-Pay” contractual risks, and securing heavy machinery.

The 2027 Summit Will Address:

The Mega-Scale Playbook: Engineering for Blockbuster GLP-1 & Peptide Volumes

  • The 500M+ Unit Facility Blueprint: Designing factory layouts and utilities optimized for high-speed automated lines running over 500,000 units per day.
  • De-risking High-Volume Tech Transfers: Transitioning complex peptide formulations from low-volume clinical development to high-speed commercial lines without yield loss.
  • The Primary Packaging Interface: Integrating high-speed syringe filling with automated secondary assembly into complex mechanical autoinjector pens.